India to United States: Febuxostat Export Trade Route

The India to United States Febuxostat corridor is one of India's established pharmaceutical export routes, with 137 shipments documented worth a combined $6.7M USD. The route is dominated by ALEMBIC PHARMACEUTICALS LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's febuxostat manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $48.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with febuxostat's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 15.8%, placing it at rank #3 among India's top febuxostat export destinations globally.

On the import side, key buyers of Indian febuxostat in United States include J KNIPPER COMPANY, TO THE ORDER OF, J. KNIPPER & COMPANY, and 19 others. J KNIPPER COMPANY is the single largest importer with 20 shipments valued at $1.3M USD.

India's febuxostat exports to United States are driven primarily by a handful of large-scale manufacturers. ALEMBIC PHARMACEUTICALS LIMITED with 38 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ALEMBIC PHARMACEUTICALS LIMITED, MSN LABORATORIES PRIVATE LIMITED, INDOCO REMEDIES LIMITED — together account for 77% of total trade value on this route. The average shipment value of $48.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as febuxostat tablets 80mg 30's ap us and febuxostat tablets 40mg 30's ap us, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, J KNIPPER COMPANY is the largest importer with 20 shipments worth $1.3M USD — representing 20% of all febuxostat imports from India on this route. A total of 22 buyers are active on this corridor.